Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies-Reference-Cited by-同舟云学术

Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies

Published:2024-06 Issue:3 Volume:57 Page:403-413
ISSN:1684-1182
Container-title:Journal of Microbiology, Immunology and Infection
language:en
Short-container-title:Journal of Microbiology, Immunology and Infection

Author:

Wu Tzong-Yow,Tsai Wan-Ting,Chen Kai-Hsiang,Huang Szu-Ting,Huang Chun-Fu,Kuo Po-Hsien,Tsai Ming-Jui,Liu Wang-Da^ORCID,Lin Kuan-Yin^ORCID,Huang Yu-Shan,Cheng Aristine,Chen Pao-Yu,Sun Hsin-Yun^ORCID,Huang Huai-Hsuan^ORCID,Huang Tai-Chung,Wu Shang-Ju,Yao Ming,Wang Jann-Tay,Sheng Wang-Huei,Hung Chien-Ching,Chen Yee-Chun^ORCID,Chang Shan-Chwen

Publisher

Elsevier BV

Reference57 articles.

1. WHO coronavirus (COVID-19) dashboard,2023

2. Factors associated with COVID-19-related death using OpenSAFELY;Williamson;Nature,2020

3. When hematologic malignancies meet COVID-19 in the United States: infections, death and disparities;Wang;Blood Rev,2021

4. Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study;Oliva;Infection,2022

5. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA);Pagano;J Hematol Oncol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation;Infectious Agents and Cancer;2024-08-12